Excision BioTherapeutics
Pre-clinicalExcision BioTherapeutics develops CRISPR-based gene therapies to treat viral infectious diseases and genetic disorders.
Founded
2015
Focus
BiologicsRNA & Gene Therapy
About
Excision BioTherapeutics develops CRISPR-based gene therapies to treat viral infectious diseases and genetic disorders.
Funding History
3Total raised: $150M
Series B$80MNorwest Venture PartnersJan 15, 2023
Series A$60MARTIS VenturesMay 15, 2021
Seed$10MARTIS VenturesJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile